ibudilast has been researched along with Analgesic Overuse Headache in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibudilast was generally well-tolerated with mild, transient nausea reported as the most common adverse event (66." | 2.80 | Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety. ( Hutchinson, MR; Johnson, JL; Johnson, K; Kwok, YH; Rolan, PE; Sumracki, NM; Swift, JE; Tuke, J; Williams, DB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, JL | 1 |
| Kwok, YH | 1 |
| Sumracki, NM | 1 |
| Swift, JE | 1 |
| Hutchinson, MR | 1 |
| Johnson, K | 1 |
| Williams, DB | 1 |
| Tuke, J | 1 |
| Rolan, PE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ibudilast and Analgesic Overuse Headache
| Article | Year |
|---|---|
Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety.
Topics: Adult; Area Under Curve; Double-Blind Method; Female; Headache Disorders, Secondary; Humans; Hyperal | 2015 |